Fmr LLC Tyme Technologies, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.35 $3 - $4	-14 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.28 - $0.68 $1,200 - $2,914	-4,286 Reduced 99.67%	14 $0
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.04 $2,580 - $4,472	4,300 New	4,300 $3,000
Q3 2021 Nov 15, 2021	SELL	$0.99 - $1.38 $0 - $1	-1 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.14 - $1.87 $1 - $1	1 New	1 $0

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.